EPINEPHRINE DELIVERY SYSTEMS – Amends existing law to revise provisions regarding the use of epinephrine in schools.
Summary
House Bill 531 revises Idaho’s school health and safety laws governing epinephrine delivery systems, commonly used for severe allergic reactions and anaphylaxis. The bill updates existing provisions that require school districts to adopt policies allowing students to self-administer prescribed epinephrine auto-injectors, inhalers, insulin, and blood glucose monitoring supplies. It also clarifies definitions and terminology related to epinephrine delivery systems and self-administration.
The bill expands and refines school authority to maintain stock epinephrine and to authorize school nurses and designated personnel to provide or administer epinephrine to students, and in emergencies to any student or other person on school premises whom staff in good faith believe is experiencing anaphylaxis. It also allows schools to obtain epinephrine through manufacturers or third-party suppliers at fair market, reduced, or no cost, and requires incident reporting and staff training standards for schools that participate in the program.
Impact
The bill amends Sections 33-520 and 33-520A of the Idaho Code, affecting public and nonpublic schools, school districts, charter districts, school nurses, designated school personnel, and medical professionals who prescribe or dispense epinephrine. It strengthens the legal framework for stock epinephrine programs in schools, broadens emergency use authority, and adds reporting and training requirements. It also preserves and expands civil liability protections for providers and schools acting reasonably, while excluding gross negligence, reckless conduct, and willful or wanton behavior. The act is declared an emergency and takes effect July 1, 2026.
Sentiment
The bill appears to have been broadly supported and noncontroversial in the legislature. It passed the House 66-0 and the Senate 31-0, indicating unanimous approval in both chambers. The absence of recorded committee transcript discussion suggests little visible opposition or debate in the available record.
Contention
No major points of contention are reflected in the available materials. The main policy choices in the bill involve how broadly schools may stock and administer epinephrine, who may be trained to use it, and the scope of liability protection for schools and medical providers. Any potential concerns would likely center on training standards, emergency administration to individuals without a prescription, and the extent of immunity, but the unanimous votes suggest these issues did not generate significant opposition.